Results 261 to 270 of about 9,409,354 (304)

WHO classification of skin tumours: key updates in the fifth edition

open access: yesHistopathology, Volume 88, Issue 3, Page 555-568, February 2026.
This review article summarizes the key updates in the 5th edition of the WHO Classification of Skin Tumours. It provides an overview of the major changes and new entities specific to the skin section, covering areas such as epidermal, melanocytic, mesenchymal and other tumours. The 5th edition of the World Health Organization Classification of Tumours (
Gabrielle Goldman‐Lévy   +29 more
wiley   +1 more source

First simultaneous identification of Moraxella bovoculi and Moraxella bovis in one-humped camel (Camelus dromedaries) in the Sahara Desert. [PDF]

open access: yesTrop Anim Health Prod
Ramo MLÁ   +10 more
europepmc   +1 more source

Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study

open access: yesInternational Journal of Dermatology, Volume 65, Issue 2, Page 299-306, February 2026.
ABSTRACT Background Conjunctivitis is among the most frequent adverse events (AEs) emerged in clinical trials for all biologic drugs approved for atopic dermatitis (AD). However, real‐world comparative data on the incidence, risk factors, and management of conjunctivitis remain limited.
Luca Potestio   +50 more
wiley   +1 more source

Interdisciplinary Approach in Pediatric Patients With Recessive Dystrophic Epidermolysis Bullosa: Experience From the Dermatology Service and the Palliative Care and Complex Chronic Patient Team at Sant Joan de Déu Hospital (Barcelona, Spain)

open access: yesJournal of Evaluation in Clinical Practice, Volume 32, Issue 1, February 2026.
ABSTRACT Background and Aims Epidermolysis bullosa is a rare genetic disorder causing extreme mucocutaneous fragility, requiring specialized, multidisciplinary care. Integrating palliative care into Epidermolysis bullosa management has proven beneficial in symptom control and psychosocial support.
Juan Manuel Martínez‐Ripoll   +2 more
wiley   +1 more source

Enhanced Imaging of Ocular Surface Lesions. [PDF]

open access: yesJ Clin Med
Najdawi WO   +6 more
europepmc   +1 more source

Comorbidities in People With Intellectual Disability With and Without Schizophrenia and Schizophrenia Without Intellectual Disability: A Swedish Register Study (IDcare)

open access: yesJournal of Intellectual Disability Research, Volume 70, Issue 2, Page 206-217, February 2026.
ABSTRACT Background Intellectual disability (ID) and schizophrenia are known to separately carry a high risk of comorbidity of mental health and physical conditions. However, the prevalence and risk of comorbidities among people diagnosed with concurrent ID and schizophrenia have to date not been studied.
Trine Lise Bakken   +2 more
wiley   +1 more source

Sarcoidosis: A Mimicker of Ocular Cicatricial Pemphigoid. [PDF]

open access: yesCureus
Murati Calderon RA   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy